Cognition is a critical aspect of psychopathology. The aim of this review is to evaluate and discuss evidence on the biological and neuropsychological markers of cognitive dysfunction in unipolar and bipolar Depression to improve the differential diagnosis and develop plans of personalized pharmacological treatment. The different use of biological and neuropsychological markers is reviewed and their use to support the clinical process and differential diagnosis is critically examined. While biological markers can help to reduce the risk of misdiagnosis, neuropsychological markers can be assessed more readily and with a less invasive methodology. To this end, additional research on the thresholds differentiating the cognitive dysfunction in unipolar and bipolar Depression should be conducted on specific psychometric tools proposed in this review. Most importantly future effort should be directed towards the validation of both types of markers specifically for these two populations. Finally this review contributes to the field by focusing on the clinical need of a precise differential diagnosis that, when put in a translational framework, should combine an integration of research and clinical practice allowing for a better understanding of mental health and for evidence-based clinical practice.

Biological and neuropsychological markers of cognitive dysfunction in unipolar vs bipolar Depression: What evidence do we have?

Platania G. A.
Primo
;
Varrasi S.
Secondo
;
Castellano S.;Godos J.;Pirrone C.;Petralia M. C.;Cantarella R. A.;Tascedda F.;Guerrera C. S.;Buono S.;Caraci F.;Blom J. M. C.
Ultimo
2020-01-01

Abstract

Cognition is a critical aspect of psychopathology. The aim of this review is to evaluate and discuss evidence on the biological and neuropsychological markers of cognitive dysfunction in unipolar and bipolar Depression to improve the differential diagnosis and develop plans of personalized pharmacological treatment. The different use of biological and neuropsychological markers is reviewed and their use to support the clinical process and differential diagnosis is critically examined. While biological markers can help to reduce the risk of misdiagnosis, neuropsychological markers can be assessed more readily and with a less invasive methodology. To this end, additional research on the thresholds differentiating the cognitive dysfunction in unipolar and bipolar Depression should be conducted on specific psychometric tools proposed in this review. Most importantly future effort should be directed towards the validation of both types of markers specifically for these two populations. Finally this review contributes to the field by focusing on the clinical need of a precise differential diagnosis that, when put in a translational framework, should combine an integration of research and clinical practice allowing for a better understanding of mental health and for evidence-based clinical practice.
2020
Bipolar Depression
Cognitive dysfunction
Differential diagnosis
Psychometric
Unipolar Depression
File in questo prodotto:
File Dimensione Formato  
2020 - Biological and neuropsychological markers of cognitive dysfunction in unipolar vs bipolar Depression What evidence do we have.pdf

solo gestori archivio

Tipologia: Versione Editoriale (PDF)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 314.92 kB
Formato Adobe PDF
314.92 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11769/574273
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 6
social impact